Camille Benoist

26 Rue D'Ulm
Paris, 75005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.

BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.

Journal: Breast cancer (Tokyo, Japan)

Published: December 05, 2025

E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

Journal: Nature communications

Published: June 18, 2025

E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma.

E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 04, 2023

Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas.

Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: July 20, 2023

Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression.

Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: April 02, 2022

Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings.

Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings.

Journal: The American journal of surgical pathology

Published: May 05, 2021

Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis.

Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 18, 2021

Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).

Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).

Journal: The Journal of molecular diagnostics : JMD

Published: March 14, 2021

Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers.

Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers.

Journal: The Journal of molecular diagnostics : JMD

Published: January 31, 2021

A single droplet digital PCR for ESR1 activating mutations detection in plasma.

A single droplet digital PCR for ESR1 activating mutations detection in plasma.

Journal: Oncogene

Published: July 30, 2019

Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).

Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).

Journal: Journal of hematology & oncology

Published: July 26, 2018

Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.

Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.

Journal: ESMO open

Published: February 08, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026